| 000 | 01541 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517064938.0 | ||
| 264 | 0 | _c20161005 | |
| 008 | 201610s 0 0 eng d | ||
| 022 | _a1936-2625 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLi, Ming | |
| 245 | 0 | 0 |
_aLuteolin improves the impaired nerve functions in diabetic neuropathy: behavioral and biochemical evidences. _h[electronic resource] |
| 260 |
_bInternational journal of clinical and experimental pathology _c2015 |
||
| 300 |
_a10112-20 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xdrug therapy |
| 650 | 0 | 4 |
_aDiabetic Neuropathies _xdrug therapy |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aGanglia, Spinal _xdrug effects |
| 650 | 0 | 4 |
_aHyperalgesia _xdrug therapy |
| 650 | 0 | 4 |
_aLuteolin _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMalondialdehyde _xmetabolism |
| 650 | 0 | 4 |
_aNeural Conduction _xdrug effects |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
| 650 | 0 | 4 |
_aPain Threshold _xdrug effects |
| 650 | 0 | 4 | _aPhysical Stimulation |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aLi, Qiang | |
| 700 | 1 | _aZhao, Qingsong | |
| 700 | 1 | _aZhang, Jinchao | |
| 700 | 1 | _aLin, Jiang | |
| 773 | 0 |
_tInternational journal of clinical and experimental pathology _gvol. 8 _gno. 9 _gp. 10112-20 |
|
| 999 |
_c25495970 _d25495970 |
||